ATE297985T1 - Orale impfstoffe gegen yersinia pestis infektionen - Google Patents

Orale impfstoffe gegen yersinia pestis infektionen

Info

Publication number
ATE297985T1
ATE297985T1 AT95910622T AT95910622T ATE297985T1 AT E297985 T1 ATE297985 T1 AT E297985T1 AT 95910622 T AT95910622 T AT 95910622T AT 95910622 T AT95910622 T AT 95910622T AT E297985 T1 ATE297985 T1 AT E297985T1
Authority
AT
Austria
Prior art keywords
transforming
constructs
microorganisms
vaccines against
yersinia pestis
Prior art date
Application number
AT95910622T
Other languages
English (en)
Inventor
Richard William Titball
Ethel Diane Williamson
Sophie Emma Clare Leary
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE297985T1 publication Critical patent/ATE297985T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT95910622T 1994-03-08 1995-03-06 Orale impfstoffe gegen yersinia pestis infektionen ATE297985T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9404577A GB9404577D0 (en) 1994-03-08 1994-03-08 Vaccine compositions
PCT/GB1995/000481 WO1995024475A1 (en) 1994-03-08 1995-03-06 Vaccine compositions

Publications (1)

Publication Number Publication Date
ATE297985T1 true ATE297985T1 (de) 2005-07-15

Family

ID=10751562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910622T ATE297985T1 (de) 1994-03-08 1995-03-06 Orale impfstoffe gegen yersinia pestis infektionen

Country Status (8)

Country Link
EP (1) EP0753061B1 (de)
JP (1) JPH09511139A (de)
AT (1) ATE297985T1 (de)
AU (1) AU1853995A (de)
CA (1) CA2184902A1 (de)
DE (1) DE69534280T2 (de)
GB (1) GB9404577D0 (de)
WO (1) WO1995024475A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615022D0 (en) * 1996-07-17 1996-09-04 Mini Agriculture & Fisheries Vaccine preparations
US20070043215A1 (en) 1996-08-27 2007-02-22 Heath David G Recombinant f1-v plague vaccine
WO2005023205A2 (en) * 2003-03-07 2005-03-17 University Of Massachusetts Compositions and methods for yersinia pestis treatment
WO2006110881A2 (en) * 2005-04-12 2006-10-19 Michigan State University Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins

Also Published As

Publication number Publication date
DE69534280D1 (de) 2005-07-21
WO1995024475A1 (en) 1995-09-14
DE69534280T2 (de) 2006-03-16
AU1853995A (en) 1995-09-25
CA2184902A1 (en) 1995-09-14
GB9404577D0 (en) 1994-04-20
EP0753061B1 (de) 2005-06-15
JPH09511139A (ja) 1997-11-11
EP0753061A1 (de) 1997-01-15

Similar Documents

Publication Publication Date Title
CY1122869T1 (el) Πολυπεπτιδικα εμβολια για ευρεια προστασια εναντι υπερλοιμογονων μηνιγγιτιδοκοκκικων γενεαλογικων σειρων
Saxena et al. Pre-existing immunity against vaccine vectors–friend or foe?
BR9605153B1 (pt) vacina de combinação, e, kit de vacinação.
DE69625802D1 (de) Impfstoffe gegen die pest
ATE233101T1 (de) Polynukleotide vakzine gegen den papilloma virus
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
ATE219948T1 (de) Rekombinante impfstoffe die immunogene attenuierte rpos-positiv phentotyp bakterien enthalten
HUP0301180A2 (hu) Imidazokinolinaminok adjuvánsként való használata DNS vakcinálásban
HU9904549A (en) Vaccines
NO20075901L (no) Forbindelser for immunterapi og diagnose av tuberkolose og metoder for deres anvendelse
Vanloubbeeck et al. The immunology of Leishmania infection and the implications for vaccine development
IL107262A0 (en) Oral vaccines comprising multiple emulsions and methods of preparation
WO2002034773A3 (en) Streptococcal genes
DE602004028029D1 (en) Rwendung
DE69515340T2 (de) Impfstoff gegen mycobakterielle infektionen
DE69828182D1 (de) Polynukleotid-impfstoff-formulierungen
DE69534280D1 (de) Orale impfstoffe gegen yersinia pestis infektionen
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
Fredriksen et al. Intramuscular challenge of rainbow trout (Oncorhynchus mykiss) with two Norwegian field strains of Flavobacterium psychrophilum
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
AR019785A1 (es) Pestivirus no diseminantes
DE60235809D1 (de) Nukleinsäurefreie ghost zusammensetzungen
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
CY1107374T1 (el) Εμβολιο ιχθυος εναντι της piscirickettsia salmonis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties